Improving Frailty in Patients With Stable Ischemic Heart Disease

Impact of a Program Aimed at Improving Frailty in Patients With Stable Ischemic Heart Disease in Primary Care: Fragicor Study

The goal of this clinical trial is to improve the frailty in old patients who have a cardiac disease .

Researchers will determine the improvement in the instability and the strength along twelve sessions based on guided exercises and mobility techniques made by physiotherapists. Research team will also evaluate the medications and diet, as well as laboratory and clinical tests.

Intitial visit to measure quality of life, instability and strenght, followed by twelve sessions, one each week will be performed

Inclusion Criteria:

• Age ≥ 70 years
• Diagnosis of coronary artery disease (International Classification Diseases (ICD)-10 I20-I25)
• Canadian Cardiovascular Society Class I
• Low cardiovascular risk according to exclusion criteria

Exclusion Criteria:

• Inability or refusal to provide informed consent (advanced dementia, severe psychiatric illness)
• Inability to perform protocol procedures
• Severe mobility-limiting conditions (Parkinson's disease, progressive neurological disorders, disabling joint disease)
• Recent (<6 months) unstable angina, myocardial infarction, coronary revascularization or angioplasty
• Deep venous thrombosis or pulmonary embolism in the last 6 months
• Recent stroke (<6 months)
• Heart failure in New York Heart Assocaition functional status (NYHA) III-IV
• Left ventricular ejection fraction < 50%
• Symptomatic valvular heart disease